Treatment of relapsed small cell lung cancerPOSTMUS, Pieter E; SMIT, Egbert F.Seminars in oncology. 2001, Vol 28, Num 2, pp 48-52, issn 0093-7754, SUP4Conference Paper

Toward less futile surgery in non-small cell lung cancer? A randomized clinical trial to evaluate the cost-effectiveness of positron emission tomographyVAN TINTEREN, Harm; HOEKSTRA, Otto S; SMIT, Egbert F et al.Controlled clinical trials. 2001, Vol 22, Num 1, pp 89-98, issn 0197-2456Article

Economic evaluation of three two-drug chemotherapy regimens in advanced non-small-cell lung cancerNEYMARK, Niels; LIANES, Pilar; SMIT, Egbert F et al.PharmacoEconomics (Auckland). 2005, Vol 23, Num 11, pp 1155-1166, issn 1170-7690, 12 p.Article

Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapyMELLEMA, Wouter W; VAN DER HOEK, Dorien; POSTMUS, Pieter E et al.Lung cancer. 2014, Vol 86, Num 1, pp 73-77, issn 0169-5002, 5 p.Article

Time and dose-related changes in radiological lung density after concurrent chemoradiotherapy for lung cancerPHERNAMBUCQ, Erik C. J; PALMA, David A; VINCENT, Andrew et al.Lung cancer. 2011, Vol 74, Num 3, pp 451-456, issn 0169-5002, 6 p.Article

Fluorescence bronchoscopy for early detection of lung cancer: A clinical perspectiveSUTEDJA, Tom G; VENMANS, Ben J; SMIT, Egbert F et al.Lung cancer. 2001, Vol 34, Num 2, pp 157-168, issn 0169-5002Article

Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatinRECK, Martin; THATCHER, Nick; SMIT, Egbert F et al.Lung cancer. 2012, Vol 78, Num 3, pp 276-281, issn 0169-5002, 6 p.Article

Absolute Quantification of [¹¹C]docetaxel Kinetics in Lung Cancer Patients Using Positron Emission TomographyVAN DER VELDT, Astrid A. M; LUBBERINK, Mark; RIJNDERS, Anneloes Y et al.Clinical cancer research (Print). 2011, Vol 17, Num 14, pp 4814-4824, issn 1078-0432, 11 p.Article

Traditional versus up-front [¹⁸F] fluorodeoxyglucose- positron emission tomography staging of non-small-cell lung cancer : A dutch cooperative randomized studyHERDER, Gerarda J. M; KRAMER, Henk; PAUL, Marinus A et al.Journal of clinical oncology. 2006, Vol 24, Num 12, pp 1800-1806, issn 0732-183X, 7 p.Conference Paper

Elevated hTERT mRNA levels: A potential determinant of bronchial squamous cell carcinoma (in situ)SNIJDERS, Peter J. F; BREUER, Roderick H. J; VAN DER ZEE, Ate G. J et al.International journal of cancer. 2004, Vol 109, Num 3, pp 412-417, issn 0020-7136, 6 p.Article

Methods to monitor response to chemotherapy in non-small cell lung cancer with ¹⁸F-FDG PETHOEKSTRA, Corneline J; HOEKSTRA, Otto S; STROOBANTS, Sigrid G et al.The Journal of nuclear medicine (1978). 2002, Vol 43, Num 10, pp 1304-1309, issn 0161-5505, 6 p.Article

Time for Reappraisal of Extracranial Treatment Options?: Synchronous Brain Metastases From Nonsmall Cell Lung CancerLIND, Joline S. W; LAGERWAARD, Frank J; SMIT, Egbert F et al.Cancer. 2011, Vol 117, Num 3, pp 597-605, issn 0008-543X, 9 p.Article

Oral Nutritional Supplements Containing (n-3) Polyunsaturated Fatty Acids Affect the Nutritional Status of Patients with Stage III Non-Small Cell Lung Cancer during Multimodality TreatmentVAN DER MEIJ, Barbara S; LANGIUS, Jacqueline A. E; SMIT, Egbert F et al.The Journal of nutrition. 2010, Vol 140, Num 10, pp 1774-1780, issn 0022-3166, 7 p.Article

Meta-Analysis of Single-Agent Chemotherapy Compared With Combination Chemotherapy As Second-Line Treatment of Advanced Non-Small-Cell Lung CancerDI MAIO, Massimo; CHIODINI, Paolo; PERRONE, Francesco et al.Journal of clinical oncology. 2009, Vol 27, Num 11, pp 1836-1843, issn 0732-183X, 8 p.Article

Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancerVAN MEERBEECK, Jan P; KRAMER, Gijs W. P. M; SPLINTER, Ted A. W et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 6, pp 442-450, issn 0027-8874, 9 p.Article

Quality assurance of thoracic radiotherapy in EORTC 08941 : A randomised trial of surgery versus thoracic radiotherapy in patients with stage IIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapyKRAMER, Gijsbert W. P. M; LEGRAND, Catherine L; GIACCONE, Giuseppe et al.European journal of cancer (1990). 2006, Vol 42, Num 10, pp 1391-1398, issn 0959-8049, 8 p.Article

European organization for research and treatment of cancer (EORTC) 08957 Phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancerARDIZZONI, Andrea; MANEGOLD, Christian; NEUMAIER, Carlo et al.Clinical cancer research. 2003, Vol 9, Num 1, pp 143-150, issn 1078-0432, 8 p.Article

Outcomes of Stereotactic Ablative Radiotherapy in Patients With Potentially Operable Stage I Non-Small Cell Lung CancerLAGERWAARD, Frank J; VERSTEGEN, Naomi E; HAASBEEK, Cornelis J. A et al.International journal of radiation oncology, biology, physics. 2012, Vol 83, Num 1, pp 348-353, issn 0360-3016, 6 p.Article

Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed―carboplatinTISEO, Marcello; GIOVANNETTI, Elisa; ARDIZZONI, Andrea et al.Lung cancer. 2012, Vol 78, Num 1, pp 92-99, issn 0169-5002, 8 p.Article

Comprehensive CADM1 promoter methylation analysis in NSCLC and normal lung specimensVAN DEN BERG, Remco M; SNIJDERS, Peter J. F; GRÜNBERG, Katrien et al.Lung cancer. 2011, Vol 72, Num 3, pp 316-321, issn 0169-5002, 6 p.Article

Weekly Chemoradiation (Docetaxel/Cisplatin) Followed by Surgery in Stage III NSCLC; a Multicentre Phase II StudyMAAS, Klaartje W; EL SHAROUNI, Sherif Y; SCHRAMEL, Franz M. N. H et al.Anticancer research. 2010, Vol 30, Num 10, pp 4237-4243, issn 0250-7005, 7 p.Article

Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung CancerSOCINSKI, Mark A; SMIT, Egbert F; JASSEM, Jacek et al.Journal of clinical oncology. 2009, Vol 27, Num 28, pp 4787-4792, issn 0732-183X, 6 p.Article

A parallel dose-escalation study of weekly and twice-weekly bortezomib in combination with gemcitabine and cisplatin in the first-linetreatment of patients with advanced solid tumorsVOORTMAN, Jens; SMIT, Egbert F; HONEYWELL, Richard et al.Clinical cancer research. 2007, Vol 13, Num 12, pp 3642-3651, issn 1078-0432, 10 p.Article

Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: The PLUS studyVERBOOM, Paul; VAN TINTEREN, Harm; VAN MOURIK, Johan C et al.European journal of nuclear medecine and molecular imaging Print. 2003, Vol 30, Num 11, pp 1444-1449, issn 1619-7070, 6 p.Article

Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patientsKLEIN, Martin; TAPHOORN, Martin J. B; CLEIJNE, Wilmy et al.Journal of clinical oncology. 2001, Vol 19, Num 20, pp 4037-4047, issn 0732-183XArticle